查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1841962

病理学人工智慧市场规模、份额和趋势分析报告：按组件、技术、应用、最终用途、地区和细分市场预测，2025 年至 2033 年

AI In Pathology Market Size, Share & Trends Analysis Report By Component, By Technology, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

病理学人工智慧市场摘要

2024 年全球病理学人工智慧市场价值估计为 1.3457 亿美元，预计到 2033 年将达到 11.5155 亿美元，2025 年至 2033 年的复合年增长率为 27.18%。

精准医疗需求的不断增长、慢性病的盛行率上升以及技术进步是推动市场成长的关键因素。

此外，病理基础设施的数位化不断提高、监管支持性发展以及产业合作也不断强化市场环境。精准医疗需求的不断成长是病理学人工智慧市场的关键驱动力之一。透过将组织病理学影像分析与基因组数据结合，人工智慧能够提供更准确的疾病分类和预后预测，从而促进个人化治疗。例如，2025年7月，LG AI Research推出了升级版病理学人工智慧模型“EXAONE Path 2.0”，以增强癌症诊断和药物开发。该系统结合了全切片影像和小块影像的分析，以避免特征崩溃并保留上下文资讯。模型基于包括DNA、RNA和全切片病理影像在内的多组体学资料进行训练，可分析基因突变、基因表现和细微的组织变化，预测准确率高达78.4%。

此外，人工智慧研究和医疗数位转型计画资金的增加，以及远距病理学应用的日益普及，正在支援人工智慧工具的大规模部署。例如，2025年3月，Proscia获得了5000万美元的融资，用于加速其基于人工智慧的Concentriq平台（一款由人工智慧驱动的病理学解决方案）的采用，整合更多人工智慧功能，并利用与安捷伦科技和西门子医疗等原始设备製造商（OEM）的伙伴关係。

优化工作流程和简化实验室操作也是推动人工智慧病理学解决方案应用的主要驱动力。组织分割、细胞计数和测量等常规任务的人工智慧自动化减少了人工工作和人为错误，使病理学家能够将更多时间投入复杂的病例。例如，2025年1月，Okin发表了关于数位病理学和人工智慧解决方案的新发现，强调了诸如工作量和诊断复杂性导致病理学家倦怠加剧等挑战。该公司的人工智慧诊断支援快速解读全切片影像、生物标记筛检和患者预后预测，从而实现精准肿瘤学。

此外，产业伙伴关係正在强化市场环境。製药公司正在与人工智慧开发商合作，将数位病理诊断技术融入临床试验和药物开发中。例如，2025年4月，Precision for Medicine 和 PathAI 宣布建立策略伙伴关係，共同开发新型人工智慧技术，并将 PathAI 先进的数位病理功能整合到 Precision for Medicine 的临床试验和生物样本操作中。 Precision for Medicine 将利用 PathAI 的 AISight 影像管理系统和人工智慧演算法，在品管步骤中增强生物样本分析工作流程，进而提高资料的一致性和可靠性。

病理学中的人工智慧全球市场细分

本研究报告预测了2021年至2033年全球、地区和国家层面的收益和成长，并分析了每个细分领域的最新行业趋势。在本研究中，Grand View Research根据组件、技术、应用、最终用途和地区对全球病理学人工智慧市场报告进行了细分。

目录

第一章调查方法与范围

第二章执行摘要

3. 病理学人工智慧市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场前景。
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 病理学市场分析工具中的人工智慧
    • 产业分析-波特五力分析
    • PESTEL分析
  • 案例研究见解
    • 建构计算病理学中的机器学习和人工智慧工具
  • 投资金筹措场景
  • 技术分析：关键用例和应用
    • 机器学习（ML）/深度学习
    • 自然语言处理（NLP）
    • 基于电脑视觉的图像分析

第四章 病理学市场中的人工智慧：成分估计和趋势分析

  • 细分仪表板
  • 病理市场人工智慧成分波动分析
  • 全球病理学人工智慧市场规模和趋势分析（按组成部分，2021-2033 年）
  • 软体
    • 影像分析和模式识别
    • 预测分析工具
    • 工作流程自动化软体
    • 诊断决策支持
  • 硬体
    • 全幻灯片成像（WSI）扫描仪
    • 数位病理系统
    • 人工智慧显微镜
  • 服务
    • 实施与整合
    • 咨询与培训
    • 託管人工智慧服务
    • 维护和支援

第五章 病理学市场中的人工智慧：技术评估和趋势分析

  • 细分仪表板
  • 病理AI市场技术变革分析
  • 全球病理学人工智慧市场规模与趋势分析（按技术，2021-2033 年）
  • 机器学习演算法
    • 深度学习
  • 自然语言处理（NLP）
  • 基于电脑视觉的图像分析

第六章：病理学市场中的人工智慧：应用评估和趋势分析

  • 细分仪表板
  • 病理学AI市场使用变化分析
  • 2021-2033 年全球病理学人工智慧市场规模及应用趋势分析
  • 疾病诊断与分类
  • 发现预后生物标记
  • 数位幻灯片影像分析
  • 优化临床工作流程
  • 药物发现和调查病理学
  • 组织和细胞分析
  • 其他的

7. 病理学市场中的人工智慧：最终用途估计和趋势分析

  • 细分仪表板
  • 病理学人工智慧市场变化分析（按最终用途）
  • 2021 年至 2033 年全球病理学人工智慧市场规模和趋势分析（按最终用途）
  • 医院和诊断实验室
  • 生命科学公司
  • 研究机构和学术中心
  • 其他的

第八章病理学人工智慧市场：区域估计和趋势分析

  • 2024 年及 2033 年区域市占率分析
  • 区域市场仪表板
  • 2021-2033年市场规模与预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 公司/竞争对手分类
  • 战略地图
  • 2024年企业市场分析
  • 公司简介/上市公司
    • Leica Biosystems Nussloch GmbH（subsidiary of Danaher）
    • Koninklijke Philips NV
    • F. Hoffmann-La Roche Ltd.
    • PathAI
    • Proscia Inc.
    • Aiforia/Aiforia Technologies PLC
    • Ibex Medical Analytics
    • Mindpeak GmbH
    • Owkin, Inc.
    • Tempus AI
    • Indica Labs, LLC.
    • Qritive
Product Code: GVR-4-68040-758-8

AI In Pathology Market Summary

The global AI in pathology market size was estimated at USD 134.57 million in 2024 and is projected to reach USD 1,151.55 million by 2033, growing at a CAGR of 27.18% from 2025 to 2033. Growing demand for precision medicine, rising prevalence of chronic diseases, technological advancements are significant factors contributing to market growth.

Moreover, the growing digitization of pathological infrastructure, supportive regulatory progress, and industry partnerships are strengthening the market environment. The growing demand for precision medicine is one of the significant drivers of AI in pathology market. AI facilitates tailored treatments by integrating histopathological image analysis with genomic data to provide more precise disease subtyping and prognosis. For instance, in July 2025, LG AI Research unveiled its upgraded pathology AI model, EXAONE Path 2.0, to enhance cancer diagnosis and drug development. The system combines analysis of both entire slide images and smaller patches to avoid feature collapse and preserve contextual information. Trained on multi-omics data, including DNA, RNA, and whole slide pathology images, the model analyzes genetic mutations, gene expression, and subtle tissue changes with 78.4% prediction accuracy.

In addition, growing funding for AI research and healthcare digital transformation programs, alongside rising adoption of telepathology, support the deployment of AI tools on a large scale. For instance, in March 2025, Proscia secured USD 50 million in funding to accelerate the adoption of its AI-powered Concentriq platform, an AI-driven pathology solution, to integrate more AI capabilities and leverage partnerships with OEMs like Agilent Technologies and Siemens Healthineers.

Workflow optimization and operational efficiency in laboratories also significantly fuel the adoption of AI pathology solutions. AI-driven automation of routine tasks such as tissue segmentation, cell counting, and measurement reduces manual labor and human error, allowing pathologists to devote more time to complex cases. For instance, in January 2025, Owkin unveiled new insights into digital pathology and AI solutions, highlighting challenges such as rising pathologist burnout due to workload and diagnostic complexity. Their AI diagnostics support quick interpretation of whole slide images, biomarker screening, and patient outcome predictions to enable precision oncology.

Furthermore, industry partnerships are strengthening the market environment. Pharmaceutical companies are collaborating with AI developers to incorporate digital pathology into clinical trials and drug development. For instance, in April 2025, Precision for Medicine and PathAI announced a strategic collaboration to develop novel AI technologies and integrate PathAI's advanced digital pathology capabilities into Precision for Medicine's clinical trial and biospecimen operations. Precision for Medicine is expected to leverage PathAI's AISight image management system and AI algorithms to enhance biospecimen analysis workflows with quality control steps, improving data consistency and reliability.

Global AI In Pathology Market Segmentation

This report forecasts, revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented global AI in pathology market report based on component, technology, application, end use, and region.

  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
    • Image Analysis & Pattern Recognition
    • Predictive Analytics Tools
    • Workflow Automation Software
    • Diagnostic Decision Support
  • Hardware
    • Whole Slide Imaging (WSI) Scanners
    • Digital Pathology Systems
    • AI-Enabled Microscopes
  • Service
    • Implementation & Integration
    • Consulting & Training
    • Managed AI Services
    • Maintenance & Support
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Machine Learning (ML)
    • Deep Learning
    • Convolutional Neural Networks (CNNS)
    • Generative Adversarial Networks (GANS)
    • Recurrent Neural Networks (RNNS)
    • Other Neural Networks
  • Natural Language Processing (NLP)
  • Computer Vision-based Image Analysis
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Disease Diagnosis & Classification
  • Prognostic & Predictive Biomarker Discovery
  • Digital Slide Image Analysis
  • Clinical Workflow Optimization
  • Drug Discovery & Research Pathology
  • Tissue & Cell Analysis
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Diagnostic Laboratories
  • Life Sciences Companies
  • Research Institutes & Academic Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Component Segment
    • 1.2.2. Technology Segment
    • 1.2.3. Application Segment
    • 1.2.4. End Use
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. AI in Pathology Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising demand for accurate and early disease detection
      • 3.2.1.2. Technological advancements in machine learning, natural language processing, and computer vision
      • 3.2.1.3. Increasing government initiatives and regulatory support
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Data security and privacy concerns
      • 3.2.2.2. High costs of advanced devices
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. AI in Pathology Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape
      • 3.3.2.6. Social Landscape
  • 3.4. Case Study Insights
    • 3.4.1. Building tools for machine learning and artificial intelligence in computational pathology
  • 3.5. Investment & funding scenario
  • 3.6. Technology Analysis: Key Use Cases and Application
    • 3.6.1. Machine Learning (ML)/Deep Learning
    • 3.6.2. Natural Language Processing (NLP)
    • 3.6.3. Computer Vision-based Image Analysis

Chapter 4. AI In Pathology Market: Component Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global AI in Pathology Market Component Movement Analysis
  • 4.3. Global AI in Pathology Market Size & Trend Analysis, by Component, 2021 to 2033 (USD Million)
  • 4.4. Software
    • 4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.2. Image Analysis & Pattern Recognition
      • 4.4.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.3. Predictive Analytics Tools
      • 4.4.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.4. Workflow Automation Software
      • 4.4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.5. Diagnostic Decision Support
      • 4.4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5. Hardware
    • 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.5.2. Whole Slide Imaging (WSI) Scanners
      • 4.5.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.5.3. Digital Pathology Systems
      • 4.5.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.5.4. AI-Enabled Microscopes
      • 4.5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6. Services
    • 4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.6.2. Implementation & Integration
      • 4.6.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.6.3. Consulting & Training
      • 4.6.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.6.4. Managed AI Services
      • 4.6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.6.5. Maintenance & Support
      • 4.6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. AI In Pathology Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global AI in Pathology Market Technology Movement Analysis
  • 5.3. Global AI in Pathology Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 5.4. Machine Learning Algorithms
    • 5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 5.4.2. Deep learning
      • 5.4.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.4.2.2. Convolutional Neural Networks (CNNS)
        • 5.4.2.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.4.2.3. Generative Adversarial Networks (GANS)
        • 5.4.2.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.4.2.4. Recurrent Neural Networks (RNNS)
        • 5.4.2.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.4.2.5. Other Neural Networks
        • 5.4.2.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.5. Natural Language Processing (NLP)
    • 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.6. Computer Vision-based Image Analysis
    • 5.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. AI In Pathology Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global AI in Pathology Market Application Movement Analysis
  • 6.3. Global AI in Pathology Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Disease Diagnosis & Classification
    • 6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5. Prognostic & Predictive Biomarker Discovery
    • 6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6. Digital Slide Image Analysis
    • 6.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7. Clinical Workflow Optimization
    • 6.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.8. Drug Discovery & Research Pathology
    • 6.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.9. Tissue & Cell Analysis
    • 6.9.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.10. Others
    • 6.10.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. AI In Pathology Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global AI in Pathology Market End Use Movement Analysis
  • 7.3. Global AI in Pathology Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Hospitals & Diagnostic Laboratories
    • 7.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5. Life Sciences Companies
    • 7.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.6. Research Institutes & Academic Centers
    • 7.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.7. Others
    • 7.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. AI In Pathology Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2033
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 8.4. North America
    • 8.4.1. U.S.
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.4.2. Canada
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.4.3. Mexico
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. UK
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.2. Germany
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.3. France
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.4. Italy
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.5. Spain
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.6. Norway
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.7. Sweden
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Regulatory framework
      • 8.5.8.3. Competitive scenario
      • 8.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.6.2. China
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.6.3. India
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.6.4. Australia
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.6.6. Thailand
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Brazil
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.7.2. Argentina
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.8. MEA
    • 8.8.1. South Africa
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.8.2. Saudi Arabia
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.8.3. UAE
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.8.4. Kuwait
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Regulatory framework
      • 8.8.4.3. Competitive scenario
      • 8.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. Leica Biosystems Nussloch GmbH (subsidiary of Danaher)
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Koninklijke Philips N.V.
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. F. Hoffmann-La Roche Ltd.
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. PathAI
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Proscia Inc.
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Aiforia/ Aiforia Technologies PLC
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Ibex Medical Analytics
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Mindpeak GmbH
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Owkin, Inc.
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Tempus AI
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. Indica Labs, LLC.
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Product benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. Qritive
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Product benchmarking
      • 9.4.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global AI in pathology market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 4 Global AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 5 Global AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 6 Global AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 7 North America AI in pathology market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 9 North America AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 10 North America AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 11 North America AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 12 U.S. AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 13 U.S. AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 14 U.S. AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 15 U.S. AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Canada AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 17 Canada AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 18 Canada AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 19 Canada AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Mexico AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 21 Mexico AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 22 Mexico AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 23 Mexico AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 24 Europe AI in pathology market, by country, 2021 - 2033 (USD Million)
  • Table 25 Europe AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 26 Europe AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 27 Europe AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 28 Europe AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 29 UK AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 30 UK AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 31 UK AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 32 UK AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 33 Germany AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 34 Germany AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 35 Germany AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 36 Germany AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 37 France AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 38 France AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 39 France AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 40 France AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Italy AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 42 Italy AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 43 Italy AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 44 Italy AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 45 Spain AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 46 Spain AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 47 Spain AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 48 Spain AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 49 Denmark AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 50 Denmark AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 51 Denmark AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 52 Denmark AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 53 Sweden AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 54 Sweden AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 55 Sweden AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 56 Sweden AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 57 Norway AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 58 Norway AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 59 Norway AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 60 Norway AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific AI in pathology market, by country, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 66 China AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 67 China AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 68 China AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 69 China AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 70 Japan AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 71 Japan AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 72 Japan AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 73 Japan AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 74 India AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 75 India AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 76 India AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 77 India AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 78 South Korea AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 79 South Korea AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 80 South Korea AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 81 South Korea AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 82 Australia AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 83 Australia AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 84 Australia AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 85 Australia AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 86 Thailand AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 87 Thailand AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 88 Thailand AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 89 Thailand AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 90 Latin America AI in pathology market, by country, 2021 - 2033 (USD Million)
  • Table 91 Latin America AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 92 Latin America AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 93 Latin America AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 94 Latin America AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 95 Brazil AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 96 Brazil AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 97 Brazil AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 98 Brazil AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 99 Argentina AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 100 Argentina AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 101 Argentina AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 102 Argentina AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 103 MEA AI in pathology market, by country, 2021 - 2033 (USD Million)
  • Table 104 MEA AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 105 MEA AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 106 MEA AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 107 MEA AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 108 South Africa AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 109 South Africa AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 110 South Africa AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 111 South Africa AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 116 UAE AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 117 UAE AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 118 UAE AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 119 UAE AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 120 Kuwait AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 121 Kuwait AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 122 Kuwait AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 123 Kuwait AI in pathology market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Market formulation & validation
  • Fig. 5 AI in pathology market: Market outlook
  • Fig. 6 AI in pathology market: Segment outlook
  • Fig. 7 AI in pathology market: Competitive landscape outlook
  • Fig. 8 Parent market outlook
  • Fig. 9 AI in pathology market driver impact
  • Fig. 10 AI in pathology market restraint impact
  • Fig. 11 AI in pathology market: Component outlook and key takeaways
  • Fig. 12 AI in pathology market: Component movement analysis
  • Fig. 13 Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Image analysis & pattern recognition market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Predictive analytics tools market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Workflow automation software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Diagnostic decision support market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Hardware market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Whole slide imaging (WSI) scanners market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Digital pathology systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 AI-enabled microscopes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Service market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Implementation & integration market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Consulting & training market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Managed AI services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Maintenance & support market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 AI in pathology market: Technology outlook and key takeaways
  • Fig. 28 AI in pathology market: Technology movement analysis
  • Fig. 29 Machine learning algorithms market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Deep learning market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Convolutional neural networks (CNNS) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Generative adversarial networks (GANS) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Recurrent neural networks (RNNS) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Other neural networks market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Natural language processing (NLP) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Computer vision-based image analysis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 AI in pathology market: Application outlook and key takeaways
  • Fig. 38 AI in pathology market: Application movement analysis
  • Fig. 39 Disease diagnosis & classification market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Prognostic & predictive biomarker discovery market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Predictive analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Digital slide image analysis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Clinical workflow optimization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Drug discovery & research pathology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Tissue & cell analysis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 AI in pathology market: End use outlook and key takeaways
  • Fig. 48 AI in pathology market: End use movement analysis
  • Fig. 49 Hospitals & diagnostic laboratories market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Life sciences companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Research institutes & academic centers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Global AI in pathology market: Regional outlook and key takeaways
  • Fig. 54 Global AI in pathology market: Regional movement analysis
  • Fig. 55 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 U.S. key country dynamics
  • Fig. 57 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Canada key country dynamics
  • Fig. 59 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Mexico key country dynamics
  • Fig. 61 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 UK key country dynamics
  • Fig. 64 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Germany key country dynamics
  • Fig. 66 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 France key country dynamics
  • Fig. 68 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Italy key country dynamics
  • Fig. 70 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Spain key country dynamics
  • Fig. 72 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Denmark key country dynamics
  • Fig. 74 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Sweden key country dynamics
  • Fig. 76 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Norway key country dynamics
  • Fig. 78 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Japan key country dynamics
  • Fig. 81 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 China key country dynamics
  • Fig. 83 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 India key country dynamics
  • Fig. 85 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Thailand key country dynamics
  • Fig. 87 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 South Korea key country dynamics
  • Fig. 89 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Australia key country dynamics
  • Fig. 91 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 93 Brazil key country dynamics
  • Fig. 94 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 95 Argentina key country dynamics
  • Fig. 96 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 97 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 98 South Africa key country dynamics
  • Fig. 99 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 100 Saudi Arabia key country dynamics
  • Fig. 101 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 102 UAE key country dynamics
  • Fig. 103 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 104 Kuwait key country dynamics
  • Fig. 105 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)